ALKOHOLBEHANDLING - Statens Institut for Folkesundhed

72
Myrick H, Brady KT, Malcolm R. Divalproex in the treatment of alcohol withdrawal. Am J Drug Alcohol Abuse 2000;
26(1):155-160.
73
Reoux JP, Saxon AJ, Malte CA, Baer JS, Sloan KL. Divalproex sodium in alcohol withdrawal: a randomized double-blind
placebo-controlled clinical trial. Alcohol Clin Exp Res 2001; 25(9):1324-1329.
74
Johnson BA. Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proofof-concept
study. Alcohol Clin Exp Res 2004; 28(8):1137-1144.
75
Johnson BA. Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate
and other modulators of GABA or glutamate function. CNS Drugs 2005; 19(10):873-896.
76
Myrick H, Malcolm R, Brady KT. Gabapentin treatment of alcohol withdrawal. Am J Psychiatry 1998; 155(11):1632.
77
Chatterjee CR, Ringold AL. A case report of reduction in alcohol craving and protection against alcohol withdrawal by
gabapentin. J Clin Psychiatry 1999; 60(9):617.
78
Bozikas V, Petrikis P, Gamvrula K, Savvidou I, Karavatos A. Treatment of alcohol withdrawal with gabapentin. Prog Neuropsychopharmacol
Biol Psychiatry 2002; 26(1):197-199.
79
Voris J, Smith NL, Rao SM, Thorne DL, Flowers QJ. Gabapentin for the treatment of ethanol withdrawal. Subst Abus
2003; 24(2):129-132.
80
Bonnet U, Banger M, Leweke FM, Specka M, Müller BW, Hashemi T et al. Treatment of acute alcohol withdrawal with
gabapentin: results from a controlled two-center trial. J Clin Psychopharmacol 2003; 23(5):514-519.
81
Franck J, Andréasson S, Thakker KD, Wirbing P. Regionalt vårdprogram. Alkoholproblem. Stockholm, Stockholms Läns
Landsting, 2003; 1-63.
82
Favre JD, Allain H, Aubin HJ, Frija-Orvoen E, Gillet C, Lejoyeux M et al. Double-blind study of cyamemazine and diazepam
in the alcohol withdrawal syndrome. Hum Psychopharmacol 2005; 20(7):511-519.
83
Wilson A, Vulcano B. A double-blind, placebo-controlled trial of magnesium sulfate in the ethanol withdrawal syndrome.
Alcohol Clin Exp Res 1984; 8(6):542-545.
84
Zilm DH, Jacob MS, MacLeod SM, Sellers EM, Ti TY. Propranolol and chlordiazepoxide effects on cardiac arrhythmias
during alcohol withdrawal. Alcohol Clin Exp Res 1980; 4(4):400-405.
85
Snead OC III, Gibson KM. Gamma-hydroxybutyric acid. N Engl J Med 2005; 352(26):2721-2732.
86
Nimmerrichter AA, Walter H, Gutierrez-Lobos KE, Lesch OM. Double-blind controlled trial of gamma-hydroxybutyrate
and clomethiazole in the treatment of alcohol withdrawal. Alcohol Alcohol 2002; 37(1):67-73.
87
Addolorato G, Balducci G, Capristo E, Attilia ML, Taggi F, Gasbarrini G et al. Gamma-hydroxybutyric acid (GHB) in the
treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine. Alcohol Clin Exp
Res 1999; 23(10):1596-1604.
88
Soyka M, Morhart-Klute V, Horak M. A combination of carbamazepine/tiapride in outpatient alcohol detoxification.
Results from an open clinical study. Eur Arch Psychiatry Clin Neurosci 2002; 252(5):197-200.
Alkoholbehandling – en medicinsk teknologivurdering 109